Logo

American Heart Association

  40
  0


Final ID:

Sex as a modifier of outcomes in genetic cardiomyopathies

  • Tayal, Paz  ( Royal Brompton , London , United Kingdom )
  • Ho, Carolyn  ( Harvard , Boston , Massachusetts , United States )
  • Author Disclosures:
    Paz Tayal: DO NOT have relevant financial relationships | Carolyn Ho: DO have relevant financial relationships ; Consultant:Bristol Myers Squibb:Active (exists now) ; Researcher:Tenaya:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Research Funding (PI or named investigator):Biomarin:Past (completed) ; Research Funding (PI or named investigator):Lexicon:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Bristol Myers Squib:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Sanofi:Past (completed) ; Consultant:Biomarin:Past (completed) ; Consultant:Lexicon:Active (exists now) ; Consultant:Cytokinetics:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:
More abstracts on this topic:
TTR Amyloidosis: Not so rare in vulnerable populations

Goyal Parag, Argiro Alessia, Arora Pankaj

Measuring and shifting the social determinants of health in genetic heart disease

Li Jennifer, Khan Sadiya, Day Sharlene, Sanchez Eduardo

More abstracts from these authors:
Hypertrophic Cardiomyopathy: Does Genotype Matter?

Ho Carolyn, Parikh Victoria, Raymer David, Sailer Christine

Precision-Based Small Molecule Therapeutics

Ho Carolyn, Ahmad Ferhaan

You have to be authorized to contact abstract author. Please, Login
Not Available